News

February 23, 2018February 23, 2018

When Bloated, UK Women More Likely to Change Diet Than Visit Doctor

News

Women in the United Kingdom are more likely to consider changing their diet than visiting their general practitioner (GP) when feeling bloated, a study recently found. Bloating is a major ... Read more

February 21, 2018February 21, 2018

Innovation’s Kevetrin Shows Promising Results in Trial for Late-stage Ovarian Cancer

News

A Phase 2a trial testing Innovation Pharmaceuticals’ p53 modulator Kevetrin as a treatment for late-stage ovarian cancer has been completed, the company announced. The study showed positive anti-cancer results, supporting the development of an ... Read more

February 19, 2018February 19, 2018

Ovarian Cancer Screening Too Limited to Aid Women with No Genetic Risk, US Group Says in Policy Update

News

Women who show no symptoms and have no known hereditary risk for ovarian cancer should skip screening for this cancer, a U.S. task force now recommends. The U.S. Preventive Services ... Read more

February 16, 2018February 16, 2018

Early Access to Palliative Care Improves Quality of Life of Terminal Cancer Patients

News

Early access to palliative care significantly enhances the quality of life of advanced cancer patients in their final stages, British researchers reported. Palliative care focuses on the whole person, not ... Read more

February 14, 2018February 14, 2018

Genetic Discovery May Be ‘Super Assassin’ of Tumor Cells, Researcher Says

News

The nucleotide expansions that cause a number of degenerative diseases may be the reason why these patients are far less susceptible to cancer, a new study suggests. A leading researcher ... Read more

February 12, 2018February 12, 2018

Bright Light Therapy Improves Sleep Quality in Cancer Survivors, Pilot Study Shows

News

Daily sessions of bright light exposure improve sleep quality in fatigued cancer survivors, researchers found. The study, “The Effect of Systematic Light Exposure on Sleep in a Mixed Group of ... Read more

February 9, 2018

Prexasertib Shrinks Ovarian Cancer Tumors in a Third of Phase 2 Trial Participants

News

The DNA repair inhibitor prexasertib shrank the tumors of a third of the ovarian cancer patients treated with it in a Phase 2 clinical trial, preliminary results show. Its developer, Eli ... Read more

February 7, 2018February 7, 2018

Antidepressant Use Does Not Increase Epithelial Ovarian Cancer Risk, Analysis Reveals

News

Women taking antidepressants are not at increased risk for epithelial ovarian cancer, according to a large-scale analysis of eight studies. While a combination of multiple studies is the best approach to ... Read more

February 5, 2018

First Patient Dosed in Phase 3 Trial Testing VB-111 in Platinum-resistant Ovarian Cancer

News

VBL Therapeutics has successfully administered the initial dose to the first patient in its Phase 3 trial investigating the effects of VB-111 (ofranergene obadenovec) in platinum-resistant ovarian cancer. The pivotal OVAL ... Read more

February 2, 2018

‘Warm’ Chemo Given Ovarian Cancer Patients Seen to Delay Recurrence in Phase 3 Trial

News

Results from a recent phase 3 clinical trial show that a specialized type of chemotherapy delivery may delay disease recurrence in newly diagnosed, advanced ovarian cancer patients. The specialized technique, called ... Read more